CD8A and COVID-19: The single-cell technology can help to map functional and phenotypic SARS-CoV-2-specific T cell immunity across the full spectrum of exposure, infection, and disease by the first measurement of T cell perturbations in COVID-19 (e.g., the percentage of neutrophils, CD4+, and CD8+ T cells in COVID-19 cases involving children [147].